[EN] TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN<br/>[FR] DÉGRADATION DE PROTÉINE CIBLÉE À L'AIDE DE COMPOSÉS BIFONCTIONNELS QUI SE LIENT À LA LIGASE D'UBIQUITINE ET À LA PROTÉINE MCL-1 CIBLE
申请人:CAPTOR THERAPEUTICS S A
公开号:WO2022253713A1
公开(公告)日:2022-12-08
A compound of formula (I); [MCL-1 ligand moiety] - [linker] - [ligase ligand moiety] (I); or a salt, solvate, hydrate, isomer or prodrug thereof, wherein [MCL-1 ligand moiety] is a compound of Formula (A), Formula (B) or Formula (C), and its use in the treatment of cancer.
化合物的公式(I); [MCL-1配体基团] - [连接体] - [酶配体基团](I);或其盐,溶剂化物,水合物,异构体或前药,其中[MCL-1配体基团]是公式(A),公式(B)或公式(C)的化合物,并且其用于治疗癌症。